Institutional & Family Asset Management »

Brainstorm Cell Therapeutics shares owned by Institutional & Family Asset Management

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Institutional & Family Asset Management from 13F filings

Historical chart of Institutional & Family Asset Management investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Institutional & Family Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Institutional & Family Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.6k 6.0k 0.27
2023-09-30 $1.2k 6.0k 0.20
2023-06-30 $6.2k 3.0k 2.06
2023-03-31 $9.9k 3.0k 3.30
2022-12-31 $4.9k 3.0k 1.64
2022-09-30 $13k 3.0k 4.33
2022-06-30 $8.0k 3.0k 2.67
2022-03-31 $10k 3.0k 3.33
2021-12-31 $12k 3.0k 4.00
2021-09-30 $10k 3.0k 3.33
2021-06-30 $11k 3.0k 3.67
2021-03-31 $8.0k 2.0k 4.00
2020-12-31 $9.0k 2.0k 4.50
2020-09-30 $34k 2.0k 17.00
2020-06-30 $22k 2.0k 11.00
2020-03-31 $9.0k 2.0k 4.50
2019-12-31 $9.0k 2.0k 4.50
2019-09-30 $8.0k 2.0k 4.00
2019-06-30 $8.0k 2.0k 4.00
2019-03-31 $9.0k 2.0k 4.50
2018-12-31 $7.0k 2.0k 3.50
2018-09-30 $8.0k 2.0k 4.00
2018-06-30 $8.0k 2.0k 4.00
2018-03-31 $6.0k 2.0k 3.00